These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7513398)

  • 41. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2.
    Sugatani J; Igarashi T; Munakata M; Komiyama Y; Takahashi H; Komiyama N; Maeda T; Takeda T; Miwa M
    Thromb Res; 2000 Oct; 100(1):61-72. PubMed ID: 11053618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
    Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
    Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating Extracellular Vesicle Tissue Factor Activity During Orthohantavirus Infection Is Associated With Intravascular Coagulation.
    Schmedes CM; Grover SP; Hisada YM; Goeijenbier M; Hultdin J; Nilsson S; Thunberg T; Ahlm C; Mackman N; Fors Connolly AM
    J Infect Dis; 2020 Sep; 222(8):1392-1399. PubMed ID: 31722433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction.
    De Caterina R; Giannessi D; Boem A; Bernini W; Battaglia D; Michelassi C; Dell'Amico F; L'Abbate A; Patrignani P; Patrono C
    Thromb Haemost; 1985 Aug; 54(2):528-32. PubMed ID: 4082090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome.
    Yoshida Y; Shiiki H; Iwano M; Uyama H; Hamano K; Nishino T; Dohi K
    Nephron; 2001 May; 88(1):24-9. PubMed ID: 11340346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P; Kotuličová D; Staško J; Kubisz P
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
    Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of aspirin on the exercise-induced changes in platelet function and blood coagulation.
    Davies T; Lederer DA; Davies JA; McNicol GP
    Thromb Res; 1974 Jul; 5(1):69-81. PubMed ID: 4610889
    [No Abstract]   [Full Text] [Related]  

  • 53. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY; Nichols WW; Mattsson C; Teger-Nilson AC; Wallin R; Saldeen TG; Mehta JL
    Cardiovasc Res; 1995 Dec; 30(6):866-74. PubMed ID: 8746200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in parameters of the coagulation-fibrinolysis system and platelet function after OKY-046 administration to patients with ruptured aneurysm of the cerebral artery.
    Kosugi T; Nakamura M; Saitoh S; Noguchi S; Shimoji T; Minei S
    Int J Tissue React; 1991; 13(1):51-7. PubMed ID: 1909691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of platelet function and tissue plasminogen activator activity in ischemic heart disease depending on concurrence with hyperlipoproteinemia and aspirin therapy].
    Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K
    Pol Arch Med Wewn; 1997 Dec; 98(12):510-9. PubMed ID: 9640079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease.
    Hallén J; Atar D; Serebruany V
    Am J Ther; 2014; 21(2):91-8. PubMed ID: 19770797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A study of intrapartum and postpartum bleeding based on changes in blood coagulation and fibrinolysis during pregnancy].
    Fuse Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):405-10. PubMed ID: 3494090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on fibrinolysis and platelet function].
    Deguchi K; Murashima S; Nishikawa M; Shirakawa S
    Nihon Rinsho; 1992 Feb; 50(2):297-302. PubMed ID: 1613983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.